SEC Form 4

FORM 4		UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5
	Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person* Weaver Paul E (Last) (First) (Middle) 132 LONE TREE FARM ROAD (Street) NEW CANAAN CT 06840 (City) (State) (Zip)	2. Issuer Name and Ticker or Trading Symbol AMN HEALTHCARE SERVICES INC [ AMN ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X Director 10% Owner Officer (give title below) Other (specify below)
	3. Date of Earliest Transaction (Month/Day/Year) 04/17/2019
	4. If Amendment, Date of Original Filed (Month/Day/Year)	6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/17/2019		M(1)		2,153	A	$0.00	47,388	D
Common Stock	04/17/2019		M(2)		2,777	A	$0.00	50,165	D
Common Stock	04/17/2019		M(3)		4,048	A	$0.00	54,213	D
Common Stock	04/17/2019		M(4)		6,009	A	$0.00	60,222	D
Common Stock	04/17/2019		M(5)		9,563	A	$0.00	69,785	D
Common Stock	04/17/2019		M(6)		9,563	A	$0.00	79,348	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(7)	04/17/2019		M			2,153	(8)	(9)	Common Stock	2,153	$0.00	0	D
Restricted Stock Units	(10)	04/17/2019		M			2,777	(11)	(9)	Common Stock	2,777	$0.00	0	D
Restricted Stock Units	(10)	04/17/2019		M			4,048	(12)	(9)	Common Stock	4,048	$0.00	0	D
Restricted Stock Units	(10)	04/17/2019		M			6,009	(13)	(9)	Common Stock	6,009	$0.00	0	D
Restricted Stock Units	(10)	04/17/2019		M			9,563	(14)	(9)	Common Stock	9,563	$0.00	0	D
Restricted Stock Units	(10)	04/17/2019		M			9,563	(15)	(9)	Common Stock	9,563	$0.00	0	D

Explanation of Responses:

1. Common Stock acquired on the vesting of Restricted Stock Units ("RSUs").

2. The acquisition of Common Stock set forth in this row resulted from the deferred release of a RSU award granted on July 17, 2006. The reporting person elected to defer receipt of these RSUs until his retirement from the Company's Board of Directors.

3. The acquisition of Common Stock set forth in this row resulted from the deferred release of a RSU award granted on April 18, 2007. The reporting person elected to defer receipt of these RSUs until his retirement from the Company's Board of Directors.

4. The acquisition of Common Stock set forth in this row resulted from the deferred release of a RSU award granted on April 8, 2008. The reporting person elected to defer receipt of these RSUs until his retirement from the Company's Board of Directors.

5. The acquisition of Common Stock set forth in this row resulted from the deferred release of a RSU award granted on April 9, 2009. The reporting person elected to defer receipt of these RSUs until his retirement from the Company's Board of Directors.

6. The acquisition of Common Stock set forth in this row resulted from the deferred release of a RSU award granted on April 13, 2010. The reporting person elected to defer receipt of these RSUs until his retirement from the Company's Board of Directors.

7. The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

8. The RSUs were granted on April 18, 2018 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's 2019 Annual Meeting of Shareholders. The Company's 2019 Annual Meeting of Shareholders was held on April 17, 2019. Accordingly, the number of RSUs identified in this row (2,153) vested on April 17, 2019.

9. RSUs do not have an expiration date.

10. The RSUs were granted pursuant to the AMN Healthcare Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

11. The RSUs set forth in this row were granted on July 17, 2006 and vested in three tranches on each of the first, second and third anniversaries of the grant date.

12. The RSUs set forth in this row were granted on April 18, 2007 and vested in three tranches on each of the first, second and third anniversaries of the grant date.

13. The RSUs set forth in this row were granted on April 8, 2008 and vested in three tranches on each of the first, second and third anniversaries of the grant date.

14. The RSUs set forth in this row were granted on April 9, 2009 and vested in three tranches on each of the first, second and third anniversaries of the grant date.

15. The RSUs set forth in this row were granted on April 13, 2010 and vested in three tranches on each of the first, second and third anniversaries of the grant date.

Remarks:

	/s/ Denise L. Jackson, as Attorney-In-Fact on behalf of Paul E. Weaver	04/19/2019
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.